Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001883850-22-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-17 | 2022-08-16 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $645.49 | -3,513 | 60.0K | -6% | -$2.27M |
| D | 2022-08-17 | 2022-08-15 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $179.13 | +10.0K | 68.5K | +17% | +$1.79M |
| D | 2022-08-17 | 2022-08-15 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $634.25 | -6,487 | 62.0K | -9% | -$4.11M |
| D | 2022-08-17 | 2022-08-15 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -10.0K | 10.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | S | D | 76 | $639.85 | 61,907 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-16 | S | D | 86 | $649.54 | 58,470 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-16 | S | D | 766 | $648.78 | 58,556 | D | — | — | (F10) Represents volume-weighted average price of sales of 766 shares of Company stock on August 16, 2022 at prices ranging from $648.17 to $648.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 4 | Common | Common Stock | 2022-08-16 | S | D | 701 | $647.73 | 59,322 | D | — | — | (F9) Represents volume-weighted average price of sales of 701 shares of Company stock on August 16, 2022 at prices ranging from $647.20 to $647.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 5 | Common | Common Stock | 2022-08-15 | M | A | 10,000 | $179.13 | 68,470 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-15 | F | D | 6,487 | $634.25 | 61,983 | D | — | — | |
| 7 | Common | Common Stock | 2022-08-16 | S | D | 148 | $640.91 | 61,759 | D | — | — | (F2) Represents volume-weighted average price of sales of 148 shares of Company stock on August 16, 2022 at prices ranging from $640.88 to $640.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-08-16 | S | D | 537 | $641.47 | 61,222 | D | — | — | (F3) Represents volume-weighted average price of sales of 537 shares of Company stock on August 16, 2022 at prices ranging from $641.00 to $641.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 9 | Common | Common Stock | 2022-08-16 | S | D | 329 | $642.53 | 60,893 | D | — | — | (F4) Represents volume-weighted average price of sales of 329 shares of Company stock on August 16, 2022 at prices ranging from $642.13 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-08-16 | S | D | 94 | $643.37 | 60,799 | D | — | — | (F5) Represents volume-weighted average price of sales of 94 shares of Company stock on August 16, 2022 at prices ranging from $643.33 to $643.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 11 | Common | Common Stock | 2022-08-16 | S | D | 332 | $644.49 | 60,467 | D | — | — | (F6) Represents volume-weighted average price of sales of 332 shares of Company stock on August 16, 2022 at prices ranging from $644.10 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 12 | Common | Common Stock | 2022-08-16 | S | D | 119 | $645.63 | 60,348 | D | — | — | (F7) Represents volume-weighted average price of sales of 119 shares of Company stock on August 16, 2022 at prices ranging from $645.49 to $645.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 13 | Common | Common Stock | 2022-08-16 | S | D | 325 | $646.44 | 60,023 | D | — | — | (F8) Represents volume-weighted average price of sales of 325 shares of Company stock on August 16, 2022 at prices ranging from $646.27 to $646.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-15 | M | D | 10,000 | $0.00 | 10,000 | D | $179.13 · — to 2022-12-14 | 10,000 Common Stock | (F11) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |